None listed
Conditions
Brief summary
Total Knee Replacements are associated with a frequent incidence of intense postoperative pain, particularly during early attempts at mobilisation. This trial will investigate the effective of adding Ketamine to a Morphine Patient Controlled Analgesia (PCA) system in order to improve analgesic efficacy, focusing on the first 48 hours. It will also measure side effects that might emerge from adding Ketamine to a Morphine PCA, the level of patient satisfaction with their PCA, and whether the addition of Ketamine leads to less PCA use.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
Elective patients undergoing a Total Knee Replacement 18 years or older Would be able to understand the use of a Patient Controlled Analgesia (PCA) system
Exclusion criteria
An allergy to morphine or ketamine Patient inability to use a PCA Pre-existing neurological or psychiatric illnesses Evidence of severe cardiovascular, renal, hematologic or hepatic disease Patients unsuitable for the study’s standardised anaesthetic technique Patients requiring other analgesic drugs or regional techniques which may affect the appreciation of pain Alcohol and opioid dependent patients Patients with a history of chronic pain